Speakers
-
Michelle Arkin, University of California San Francisco, USA
Marianne Ashford, AstraZeneca, UK
Yimon Aye, University of Oxford, UK
Steven Banik, Stanford University, USA
Miklos Bekes, ARVINAS, USA
Robert Blelloch, University of California San Francisco, USA
Ling-Ling Chen, Shanghai Tech, China
Danette Daniels, Foghorn Therapeutics, USA
Julian Downward, Francis Crick Institute, UK
Fleur Ferguson, University of California San Diego, USA
Eric Fischer, Dana Farber, USA
Ryan Flynn, Harvard, USA
Nathanael S. Gray, Stanford University, USA
Ming Hammond, University of Utah, USA
Lingyin Li, Stanford, USA
Jennifer Petter, Arrakis Therapeutics, USA
Ingrid E. Wertz, Lyterian Therapeutics, USA
Pete Wildes, Revolution Medicines, USA
Zhong-Yin Zhang, Purdue University, USA